In line with this notion, we found that the levels γ-H2AX, as an indicator of DNA DSBs, were markedly escalated in hepatomas formed in DEN-treated mice, and this was attenuated by SFN administration (Supplementary Figure S3). The gene discussed is H2AX; the disease is hepatocellular carcinoma.